Jack Lloyd

Mr. Lloyd has founded and managed several high-tech companies in the medical device, medical service and drug delivery areas. Currently, he is Founder and Principal in several companies developing drug delivery systems and non-invasive measurement and monitoring. Previously, he was Founder of Alere Medical (monitoring patients at home for heart failure and other chronic diseases – sold to Inverness, now Alere, in 2007); Founder, President and Chairman of Aradigm (which developed, manufactured and licensed devices and systems for aerosol drug delivery for systemic effect, including insulin – IPO in 1996); Founder and President of Nellcor Incorporated (anesthesia monitoring, developer of the pulse oximeter – IPO in 1987, now part of Covidien); owned patents in digital hearing aid (licensed to ReSound and sold to Siemens in 1995); and Founder and President of Humphrey Instruments (ophthalmic instruments – sold to Smith Kline in 1980, now part of Zeiss). Mr. Lloyd has served on the public boards of Nellcor, Aradigm, Aspect Medical, and Molecular Dynamics and is a director, investor and advisor to several medical device and drug delivery companies. He presently serves as on the advisory committee to the dean of the College of Engineering at the University of California, Berkeley. Mr. Lloyd has a BSME from University of California, Berkeley and holds 30 US Patents.